Pfizer, Fudan University Jointly Train Pharmacoeconomics Professionals
This article was originally published in PharmAsia News
Executive SummaryPfizer and Fudan University recently launched a three-year professional development training program for pharmacoeconomics professionals in China, hoping to reverse a shortage in the field
You may also be interested in...
Alnylam’s Givlaari for acute hepatic porphyria is also among the 14 new products that could get an EU approval recommendation this week.